| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Nephrology, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah, United States
2 Physiology, Medical College of Georgia, Augusta, Georgia, United States
3 Cellular Biology and Anatomy, Medical College of Georgia, Augusta, Georgia, United States
* To whom correspondence should be addressed. E-mail: tianxin.yang{at}hsc.utah.edu.
Epithelial-to-mesenchymal transition (EMT) has emerged as a critical event in the pathogenesis of tubulointerstitial fibrosis. EMT is typically induced by transforming growth factor-
1 (TGF-1) and inhibited by hepatocyte growth factor (HGF). The present study was undertaken to evaluate the potential role of COX-2-derived PGE2 in regulation of EMT in cultured MDCK cells, in the setting of HGF treatment. Exposure to 50 ng/ml HGF significantly induced COX-2 protein expression and PGE2 release, whereas other growth factors, including epidermal growth factor, the insulin-like growth factor I protein, platelet-derived growth factor-BB, and TGF-1, had no effects on COX-2 expression or PGE2 release. Exposure of MDCK cells to 10 ng/ml TGF-1 for 48 hours induced EMT as evidenced by conversion to the spindle-like morphology, loss of E-cadherin, and activation of 
-smooth muscle actin (-SMA). In contrast, treatment with 1 µM PGE2 completely blocked EMT, associated with a significant elevation of intracellular cAMP and complete blockade of TGF-1-induced oxidant production. cAMP-elevating agents, including 8-Br-cAMP, forskolin, and IBMX, inhibited EMT and associated oxidative stress induced by TGF-1, but inhibition of cAMP pathway with Rp-cAMP, the cAMP analog, and H89, the protein kinase A (PKA) inhibitor did not block the effect of PGE2. The effect of HGF on EMT was inhibited by approximately 50% in the presence of a COX-2 inhibitor SC58635. Therefore, our data suggest that PGE2 inhibits EMT via cAMP-dependent inhibition of ROS production and COX-2-derived PGE2 partially accounts for the antifibrotic effect of HGF.
This article has been cited by other articles:
|
|
 |
|
  J. R. Neil, K. M. Johnson, R. A. Nemenoff, and W. P. Schiemann Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-{beta} through a PGE2-dependent mechanisms Carcinogenesis, November 1, 2008; 29(11): 2227 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jia, X. Guo, H. Zhang, M.-H. Wang, Z. Dong, and T. Yang Microsomal Prostaglandin Synthase-1-Derived Prostaglandin E2 Protects Against Angiotensin II-Induced Hypertension via Inhibition of Oxidative Stress Hypertension, November 1, 2008; 52(5): 952 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Huang and M. Peters-Golden Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time? Chest, June 1, 2008; 133(6): 1442 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Lee, Y. J. Suzuki, A. J. Griffin, and R. M. Day Hepatocyte growth factor regulates cyclooxygenase-2 expression via {beta}-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L778 - L786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ding, A. Zhang, S. Huang, X. Pan, G. Zhen, R. Chen, and T. Yang ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1889 - F1897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
